@misc{misc50953652,
title   = {Bolero-4: A Phase 2, Open-Label, multicenter, single-arm trial investigating the efficacy and safety of first-line everolimus (EVE) in combination with letrozole (LET) in postmenopausal patients (PTS) with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2–) metastatic or locally advanced unresectable breast cancer (BC)},
author = {Bachelot, Thomas and Villanueva, Cristian and Royce, Melanie and Debled, Marc and Cruz, Felipe Melo and Hegg, Roberto and Brechenmacher, Thomas and Manlius, Corinne and Ringeisen, Francois and Cardoso, Fatima},
year = {2015},
doi = {10.1016/S0960-9776(15)30068-0},
booktitle   = {Advanced Breast Cancer Third International Consensus Conference}
}